OPN Healthcare

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Neuroendocrine tumours1 trial
• Prostate cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• SystImmune Inc.2 trials

Running trials

• Recruiting

  BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  NCT07625644· Phase 3· SystImmune Inc.· Source

  Contact: Michael Nguyen (principal investigator)

• Recruiting

  Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

  NCT07080242· Phase 1· SystImmune Inc.· Source

  Contact: Heather Lyon

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Neuroendocrine tumours1 recruiting
• Prostate cancer1 recruiting